Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

Biden Supports Early COVID Treatment: Too Little, Too Late? Asks Doctors for Disaster Preparedness


TUCSON, Ariz., Jan. 20, 2022 /PRNewswire/ -- In his Jan 19 press conference, President Joe Biden pushed for vaccinating everyone against COVID-19, including babies as soon as the science shows it to be safe, as it presumably will. But he also mentioned treatment for patients who nonetheless become infected, observes Doctors for Disaster Preparedness (DDP) president Jane Orient, M.D.

"Additionally, we're increasing the availability of new medicines recommended by real doctors, not conspir?conspiracy theorists." At the press conference, he specifically named monoclonal antibodies and alluded to new pills.

Previously, Biden stated that he had doubled the government's order of Pfizer's Paxlovid, from 10 million to 20 million doses, while noting that it takes months to make a pill.

The federal government has been rationing monoclonal antibodies, which in any event are probably ineffective against the omicron variant, notes DDP.

The State of New York has received Paxlovid doses for treating only about 20,000 people. Its Health Commissioner Dr. Mary Bassett observed that that is insufficient.

Paxlovid is authorized by the FDA under an emergency use authorization (EUA). It contains a protease inhibitor, nirmatrelvir, to prevent viral replication plus the HIV drug ritonavir to prevent the protease inhibitor from being broken down. According to Pfizer press releases, Paxlovid has been effective in early treatment of mild to moderate COVID.

The Merck drug molnupiravir, which also has an EUA, could be available sooner. But because it results in genetic mutations, it is feared that it could lead to new viral variants or result in cancer or birth defects in humans.

Meanwhile, the government is hoarding in the Strategic National Stockpile some 60 million doses of hydroxychloroquine, which were donated by generous pharmaceutical companies to treat COVID-19. Hydroxychloroquine was FDA approved in 1955 and has been safely used by hundreds of millions of people for a variety of indications.

"Why is President Biden touting a medication that is mostly unavailable?" asks Dr. Orient. "And why is the government authorizing and recommending a medication that may be unsafe for many, while affordable, long-established drugs such as hydroxychloroquine and ivermectin are discouraged or suppressed?"

Doctors for Disaster Preparedness is a group of scientists (including physicians) founded in 1984, which provides information to help save lives in the event of natural or man-made disasters.

Contact: Jane M. Orient, M.D., (520) 323-3110, [email protected]

SOURCE Doctors for Disaster Preparedness


These press releases may also interest you

at 18:00
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:52
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

at 16:30
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: